Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The coronaviral frameshift-stimulatory element (FSE) RNA pseudoknot is a highly conserved structural motif found in the genomes of coronaviruses. It plays a critical role in viral protein synthesis by promoting programmed −1 ribosomal frameshifting (−1 PRF), a mechanism that allows the ribosome to shift reading frames during translation, thereby enabling the production of multiple proteins from overlapping open reading frames. Disruption or modulation of this element can inhibit viral replication because it directly affects synthesis ratios for key replicase polyproteins. Recent research has demonstrated that small molecules binding to this RNA structure can reduce −1 PRF efficiency and suppress virus propagation—making it an attractive antiviral drug target for SARS-CoV-2 and other pathogenic coronaviruses.
Small molecules binding to the FSE can reduce -1 PRF efficiency and suppress virus propagation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronaviral Frameshift-Stimulatory Element RNA Pseudoknot (Corona_FSE).